Sort
30,917 grants matching “tumor microenvironment”
Targeting S6K2 to Overcome Drug Resistance in NRAS-mutant Melanoma
$475,922Jessie Villanueva · Wistar Institute · R01 · FY2023 · CA
Novel roles of STAT2 and IFN-I in tumorigenesis and responses to therapy
$475,893George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2023 · CA
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
$475,865Timothy Patrick Spicer · Scripps Florida · R33 · FY2017 · CA
Role of EphB4-ephrin-B2 interaction in regulating crosstalk between cancer cell and vascular tumor microenvironment in head and neck cancer
$475,766Sana D Karam · University Of Colorado Denver · R01 · FY2019 · DE
Role of EphB4-ephrin-B2 interaction in regulating crosstalk between cancer cell and vascular tumor microenvironment in head and neck cancer
$475,766Sana D Karam · University Of Colorado Denver · R01 · FY2023 · DE
Role of EphB4-ephrin-B2 interaction in regulating crosstalk between cancer cell and vascular tumor microenvironment in head and neck cancer
$475,766Sana D Karam · University Of Colorado Denver · R01 · FY2020 · DE
Role of EphB4-ephrin-B2 interaction in regulating crosstalk between cancer cell and vascular tumor microenvironment in head and neck cancer
$475,766Sana D Karam · University Of Colorado Denver · R01 · FY2021 · DE
Duke-UNC Chapel Hill Immunotherapy Training Grant
$475,705Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · T32 · FY2019 · CA
Investigating the roles of extracellular cGAMP and harnessing it for cancer treatment
$475,613Aaron F Straight · Stanford University · R01 · FY2024 · CA
Novel Protein Engineered Drug Conjugates Targeting Phosphatidylserine for the Treatment of Breast Cancer
$475,608Kevin G Pinney · Baylor University · R01 · FY2021 · CA
Development of Salmonella for cancer therapeutics
$475,564Olivia Steele-Mortimer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Intraoperative Polarization-Sensitive OCT for Assessing Breast Tumor Margins
$475,541Stephen A Boppart · University Of Illinois At Urbana-Champaign · R01 · FY2018 · CA
Proj. 2: Combining immune checkpoint blockade with T cell activation
$475,430E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2022 · CA
Proj. 2: Combining immune checkpoint blockade with T cell activation
$475,430E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2023 · CA
Impact of cancer predisposition on oncogenic process, microenvironment, and treatment
$475,364Li Ding · Washington University · R01 · FY2025 · CA
Project 3 â Stromal derived IL-6/STAT3 signaling in the development and progression of PDAC
$475,342Michael C Ostrowski · Medical University Of South Carolina · P01 · FY2024 · CA
Novel immune suppressive activities of Fas/CD95 in triple negative breast cancer
$475,275Marcus E Peter · Northwestern University At Chicago · R01 · FY2022 · CA
Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain
$475,250Cyrus M Ghajar · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain
$475,250Cyrus M Ghajar · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Engineered Colon Cancer Tissue to Examine the Role of the Obese Microenvironment in Tumor Aggressiveness
$475,177Elizabeth A Lipke · Auburn University At Auburn · R01 · FY2024 · CA
Enhanced Viro-Immunotherapy for Breast Cancer Brain Metastasis
$475,165Ji Young Yoo · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · CA
Role of CREBBP missense mutations in lymphomagenesis
$475,089Laura Pasqualucci · Columbia University Health Sciences · R01 · FY2025 · CA
Role of CREBBP missense mutations in lymphomagenesis
$475,089Laura Pasqualucci · Columbia University Health Sciences · R01 · FY2022 · CA
Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines
$475,000Saad J. Kenderian · Mayo Clinic Rochester · R37 · FY2023 · CA
Colorado Head and Neck Cancer SPORE
$475,000Antonio Jimeno · University Of Colorado Denver · P50 · FY2023 · CA